- Home
- CHE
CHE
Chemed Corp
as 04-18-2025 1:33pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Chemed Corp CHE prepares to release earnings report on 23 Apr 2025.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 8.8B | IPO Year: | N/A |
| Target Price: | $667.00 | AVG Volume (30 days): | 145.8K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 19.89 | EPS Growth: | 10.93 |
| 52 Week Low/High: | $512.12 - $623.61 | Next Earning Date: | 04-23-2025 |
| Revenue: | $2,431,287,000 | Revenue Growth: | 7.37% |
| Revenue Growth (this year): | 9.04% | Revenue Growth (next year): | 6.68% |
Stock Insider Trading Activity of Chemed Corp (CHE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MCNAMARA KEVIN J | CHE | president and CEO | Mar 6 '25 | Sell | $593.67 | 2,000 | $1,187,340.00 | 102,679 | |
| LEE SPENCER S | CHE | executive vice president | Mar 3 '25 | Sell | $592.25 | 1,326 | $785,323.50 | 17,627 |
Latest Chemed Corp News
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
CHE: Raising target price to $648.00
StockStory
4 days ago
Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Zacks
5 days ago
OPCH or CHE: Which Is the Better Value Stock Right Now?
Simply Wall St.
10 days ago
Do Chemed's (NYSE:CHE) Earnings Warrant Your Attention?
Argus Research
10 days ago
CHE: Lowering target price to $629.00
Insider Monkey
12 days ago
Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy’s Holding Period
StockStory
16 days ago
Chemed (CHE): Buy, Sell, or Hold Post Q4 Earnings?
Argus Research
17 days ago
Daily – Vickers Top Buyers & Sellers for 04/02/2025
Compare CHE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.